Finance

Lists
Q3 2026 earnings • released • EPS miss -0.73% • Revenue miss -3.32%
See results
XYL:NYSE
Xylem Inc
$92.86
-14.26%
(-15.45) 1D
$93.24
+0.41% (+0.38)
Pre-market
Closed: Oct 27, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XYL...
Open
$102.00
High
$102.76
Low
$92.61
Mkt. cap
21.68B
Avg. vol.
2.36M
Volume
7.28K
Dividend
1.85%
Quarterly dividend
$0.43
Ex-dividend date
Aug 27, 2026
P/E ratio
22.08
52-wk high
$154.27
52-wk low
$92.61
EPS
$4.21
Beta
1.00
Shares outstanding
233.49M
No. of employees
22K
Open
$102.00
High
$102.76
Low
$92.61
Mkt. cap
21.68B
Avg. vol.
2.36M
Volume
7.28K
Dividend
1.85%
Quarterly dividend
$0.43
Ex-dividend date
Aug 27, 2026
P/E ratio
22.08
52-wk high
$154.27
52-wk low
$92.61
EPS
$4.21
Beta
1.00
Shares outstanding
233.49M
No. of employees
22K
News stories
From web sources and news partners
Profile
Xylem Inc. is a large American water technology provider, in public utility, industrial, commercial, agricultural and residential settings. The company does business in more than 150 countries. Launched in 2011 as the spinoff of the water-related businesses of ITT Corporation, Xylem is headquartered in Washington, DC, with 2024 revenues of $8.6 billion and 23,000 employees worldwide. Xylem made its debut on the Fortune 500 list in 2024, ranking #486. Its products and services are focused in two areas: water infrastructure, which consists of businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation; and applied water, which is residential and commercial building services companies, as well as industrial and agricultural applications. Wikipedia
About Xylem Inc
CEOMatthew F. Pine
Employees22K
Founded2011
Headquarters-
SectorMachine industry
Websitexylem.com
Analyst ratings
Based on 14 analysts giving stock ratings to XYL in the past 3 months
Buy
Buy
9
Hold
4
Sell
1
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for XYL in the last 3 months.
Highest
Current $92.86
$165.00 (+77.69%)
Average
$134.09 (+44.40%)
Lowest
$90.00 (-3.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Fairbanks
J.P. Morgan
Sell
Downgraded
$90.00
-3.1%
10/28/2026
Mark Strouse
J.P. Morgan
Hold
Maintained
$118.00
+27.1%
10/19/2026
Nathan Jones
Stifel Nicolaus
Buy
Maintained
$141.00
+51.8%
10/19/2026
Andrew Kaplowitz
Citi
Buy
Reiterated
$148.00
+59.4%
10/16/2026
Brett Linzey
Mizuho Securities
Hold
Maintained
$110.00
+18.5%
10/15/2026
Bryan Blair
Oppenheimer
Buy
Reiterated
$150.00
+61.5%
10/14/2026
William Grippin
Barclays
Buy
Maintained
$139.00
+49.7%
10/13/2026
Jeff Reive
RBC Capital
Buy
Maintained
$135.00
+45.4%
10/13/2026
Joshua Spector
UBS
Hold
Maintained
$112.00
+20.6%
10/05/2026
Unknown Analyst
CFRA
Buy
Maintained
-
-
09/17/2026
Nigel Coe
Wolfe Research
Hold
Initiated
-
-
09/15/2026
Stephen Volkmann
Jefferies
Buy
Maintained
$150.00
+61.5%
08/24/2026
Brian K. Lee
Goldman Sachs
Buy
Reiterated
$160.00
+72.3%
07/28/2026
Deane Dray
RBC Capital
Buy
Maintained
$164.00
+76.6%
07/28/2026
Michael Halloran
Robert W. Baird
Buy
Maintained
$165.00
+77.7%
07/29/2026
Joseph C Giordano
TD Cowen
Hold
Reiterated
$135.00
+45.4%
07/29/2026
Brian Drab
William Blair
Buy
Maintained
-
-
07/29/2026
Last report
Oct 27, 2026
Fiscal period
Q3 2026
$1.44 / $1.45
-0.73%miss
Revenue / Est. (USD)
2.20B / 2.28B
-3.32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.27B
2.40B
2.12B
2.34B
Cost of goods sold
1.38B
1.46B
1.32B
1.38B
Cost of revenue
1.38B
1.46B
1.32B
1.38B
Research and development expenses
52.00M
60.00M
56.00M
59.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
476.00M
489.00M
473.00M
503.00M
Operating expense
528.00M
549.00M
529.00M
562.00M
Total operating expenses
1.91B
2.01B
1.85B
1.94B
Operating income
355.00M
383.00M
274.00M
397.00M
Other non operating income
8.00M
-21.00M
1.00M
-3.00M
EBT including unusual items
297.00M
368.00M
244.00M
364.00M
EBT excluding unusual items
357.00M
385.00M
271.00M
387.00M
Income tax expense
71.00M
35.00M
55.00M
103.00M
Effective tax rate
23.91%
9.51%
22.54%
28.30%
Other operating expenses
-
-
-
-
Net income
227.00M
335.00M
193.00M
263.00M
Net profit margin
10.01%
13.98%
9.08%
11.26%
Earnings per share
1.37
1.42
1.12
1.46
Interest and investment income
-
27.00M
-
-
Interest expense
-6.00M
-6.00M
-4.00M
-7.00M
Net interest expenses
-6.00M
21.00M
-4.00M
-7.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
497.00M
526.00M
414.00M
537.00M
Gain or loss from assets sale
37.00M
-16.00M
-4.00M
16.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps